# Jasper Therapeutics, Inc.: Form 8-K, filed Aug 13, 2025

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2025-08-13
- Accepted by EDGAR: Aug 13, 2025, 16:10 ET
- Period: 2025-08-13
- Accession: 0001213900-25-075678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390025075678/ea0252991-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390025075678/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390025075678/ea0252991-8k_jasper.htm

Filed Aug 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-075678. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.